# Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

> **NCT04838392** · NA · NOT_YET_RECRUITING · sponsor: **Bionime Corporation** · enrollment: 150 (estimated)

## Conditions studied

- Diabetes Mellitus
- Type 1 Diabetes
- Type 2 Diabetes

## Interventions

- **DEVICE:** RIGHTEST Continuous Glucose Monitoring System

## Key facts

- **NCT ID:** NCT04838392
- **Lead sponsor:** Bionime Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-07
- **Final completion:** 2025-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838392, "Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04838392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*